An immunological approach to prion diseases

Medical Hypotheses

Volumn 50, Issue 1, 1998, Pages 85-90

  Paraf, A ^a  

^a CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; PRION PROTEIN;

AUTOIMMUNITY; BOVINE SPONGIFORM ENCEPHALOPATHY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; GENETIC DISORDER; HUMAN; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SCRAPIE;

ANIMALIA; BOVINAE; OVIS;

EID: 0031974008     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90182-7     Document Type: Article

References (51)

1. BSE: progress report. Food Safety Information Bulletin 1996; 18.
2. Dormont D. Les précautions à prendre pour éviter la transmission des agents transmissibles non conventionnels au cours des processus de greffe. Méd Mal Infect 1995; 25 special: 281-291.
3. Krakauer D C, Pagel M, Southwood T R E, De A Zanetto P M. Phylogenesis of prion protein. Nature 1996; 380: 675.
4. Hunter N. Scrapie in sheep and goats. In: Speedy A W, ed. Progress in Sheep and Goat Research. London: CAB International, 1992; 131-151.
5. Prusiner S B, Füzi M, Scott M et al. Immunologic and molecular biologic studies of prion proteins in bovine spongiform encephalopathy. J Infect Dis 1993; 167: 602-613.
6. Clark W, Hourigan J L, Hadlow W J. Encephalopathy in cattle experimentally infected with the scrapie agent. Am J Vet Res 1995; 56: 606-612.
7. Dickinson A G, Fraser H. The pathogenesis of scrapie in inbred mice: an assessment of host control and response involving many strains of agent. In: Meulen V T, Katz M, eds. Slow Virus infection of the Central Nervous System. New York: Springer-Verlag, 1977: 3-14.
8. Kimberlin R H, Walker C A. Pathogenesis of scrapie (Strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 1986; 67: 255-263.
9. Foster J D, Hope J, Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet Record 1993; 133: 339-341.
10. Fraser H, Bruce M E, Chree A, McConnel I, Wells G A H. Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol 1992; 73: 1891-1897.
11. Brandner S, Isenmann S, Raeber A et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996; 379: 339-343.
12. Prusiner S B. Chemistry and biology of prions. Biochemistry 1992; 31: 12277-12288.
13. Ye X, Carp R I. The pathological changes in peripheral organs of scrapie-infected animals. Histol Histopathol 1995; 10: 995-1021.
14. Barry R A, Prusiner S B. Immunology of prions. In: Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeld-Jakob Disease. New York: Academic Press, 1987: 239-276.
15. Prusiner S B, Telling G, Cohen F E, DeArmond S J. Prion diseases of humans and animals. Virology 1996; 7: 159-173.
16. Oesch B, Westaway D, Wälchli M et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985; 40: 735-746.
17. Bockman J H, Kingbuy D T, McKinley M P, Bendheim P E, Prusiner S B. Creutzfeldt-Jakob disease prion proteins in human brain. N Engl J Med 1985; 312: 73-78.
18. Basler K, Oesch B, Scott M et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 1986; 46: 417-428.
19. Hunter N, Goldmann W, Benson G, Foster J D, Hope J. PrP genotype studies. In: Bradley R, Marcant B, eds. EEC Meeting, Brussels: Proc Consultation BSE Scientific Vet Committee Commission European Communities, 1993: 25-139, 1994 - PrP gene plays a major role in determining the susceptibility to and incubation period of all the diseases caused by SE agents.
20. Gasset M, Baldwin M A, Lloyd D H et al. Predicted α-helical regions of the prion protein which synthesize as peptides from amyloid. Proc Natl Acad Sci USA 1992; 89: 10940-10944.
21. Foster J D, Bruce M, McConnell I, Chree A, Fraser H. Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet Record 1996; 138: 546-548.
22. Kazmirski S I, Alonso D O V, Cohen F E, Prusiner S B, Dagget V. Theoretical studies of sequence effects on the conformational properties of a fragment of the prion protein: implications for scrapie formation. Chem Biol 1995; 2: 305-315.
23. van Keulen L J M, Schreuder B E C, Meloen R H, Mooij-Harkes G, Vromans M E W, Langeveld J P M. Immunohistochemical detection of prion protein in lymphoid tissues of sheep with natural scrapie. J Clin Microbiol 1996; 34: 1228-1231.
24. Schreuder B E C, van Keulen L J M, Vromans M E W, Langeveld J P M, Smits M A. Preclinical test for prion diseases. Nature 1996; 381: 563.
25. Goodnow C C. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Sci Acad USA 1996; 93: 2264-2271.
26. Bons N, Mestre-Francès, Charnay Y, Tagliavini F. Spontaneous spongiform encephalopathy in a young adult rhesus monkey. Lancet 1996; 348: 55.
27. Friedman A, Weiner H L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91: 6688-6692.
28. Berg L J. Insights into the role of the immune system in prion diseases. Proc Natl Acad Sci USA 1994; 91: 429-432.
29. Carsetti R, Kölher G, Lamers M C. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995; 181: 2129-2140.
30. Monroe J G. Tolerance sensitivity of immature-stage B cells. Can developmentally regulated B cell antigen receptor (BCR) signal transduction play a role?. J Immunol 1996; 156: 2657-2660.
31. Cobbold S P, Adams E, Marshall S E, Davies J D, Waldmann H, Davies J D, Waldmann H. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol Rev 1996; 149: 5-53.
32. McCullagh P. The significance of immune suppression in normal self tolerance. Immunol Rev 1996;149: 127-153.
33. Soldevila G, Geiger T, Flavell R A. Breaking immunologic ignorance to an antigenic peptide of simian virus 40 large T antigen. J Immunol 1995; 155: 5590-5591.
34. Weiner H L, Friedman A, Miller A et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigen. Annu Rev Immunol 1994; 12: 809-837.
35. Hayglass K T, Strejan G H. Suppression of the IgE antibody response by glutaraldehyde-modified ovalbumin: dissociation between loss of antigenic reactivity and ability to induce suppression. Int Arch Allergy Appl Immunol 1984; 74: 332-349.
36. Hayglass K T, Gieni R S, Stefura W P. Long-lived reciprocal regulation of antigen-specific IgE and IgG2a responses in mice treated with glutaraldehyde-polymerized ovalbumin. Immunology 1991; 73: 407-414.
37. Chen Y, Inobe J-I, Marks R, Gonnella P, Kuchroo V, Weiner H L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995; 376: 177-180.
38. Frandji P, Oskeritzian C, Cacaraci F et al. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J Immunol 1993; 151: 6318-6328.
39. Minor D L Jr, Kim PS. Context-dependent secondary structure formation of a designed protein sequence. Nature 1996; 380: 730-734.
40. Williamson R A, Peretz D, Smorodinsky N et al. Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein. Proc Natl Acad Sci USA 1996; 93: 7279-7282.
41. Gabizon R, McKinley M, Groth D, Prusiner S B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci USA 1988; 85: 6617-6621.
42. Ikegami Y, Ito M, Isomura H et al. Vet Record 1991; March 23: 271-275.
43. Benkirane N, Guichard G, van Regenmortel M H V, Briand J-P, Muller S. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. J Biol Chem 1995; 270: 11921-11926.
44. Jensen W A, Sheehy S E, Fox M H, Davis W C, Cockerell G L. In vitro expression of bovine leukemia virus in isolated B-lymphocytes of cattle and sheep. Vet Immunol Immunopathol 1990; 26: 333-342.
45. Cheah M S C, Ley T J, Tronick S R, Robbins K C. Fgr proto-oncogene in RNA induced in B-lymphocytes by EpsteinBarr virus infection. Nature 1986; 319: 238-240.
46. Stenvenson M, Volsky D J. Activated v-myc and v-ras oncongenes do not transform normal human lymphocytes. Mol Cell Biol 1986, 6: 3410-3417.
47. Hecht S J, Stedman K E, Carlson J O, DeMartini J C. Distribution of endogenous type B and type D sheep retrovirus sequences in ungulates and other mammals. Proc Natl Acad Sci USA 1996; 93: 3297-3302.
48. Groves D J, Morris B A, Tan K, De Silva M, Clayton J. Production of an ovine monoclonal antibody to testosterone by an interspecies fusion. Hybridoma 1987; 6: 71-76.
49. Flynn J N, Harkiss G D, Hopkins J. Generation of a sheep × mouse heterohybridoma cell line (1C6.3a6T.1D7) and evaluation of its use in the production of ovine monoclonal antibodies. J Immunol Methods 1989; 121: 237-246.
50. Zhang H, Kaneko K, Nguyen J T et al. Conformational transitions in peptides containing two putative α-helices of the prion protein. J Mol Biol 1995; 250: 514-526.
51. Mehlhorn I, Groth D, Stockel J et al. High level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry 1996; 35: 5528-5537.